Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders ...

Arguably, the most important thing you can have in this life is your health. No matter how much money you have or resources ...

Organ transplants are a "never-ending tragedy," with referrals steadily going up while the number of organs available remains ...

Most days, our bodies are just there—mundane vessels we inhabit on autopilot. We wake up, get on with our routines, eat, sleep, repeat. But the moment you actually stop and think about what’s ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Memantine, a cheaply available drug used for decades to treat Alzheimer's, may help prevent sickle cell crises, especially in ...